Tamper-Resistant Hydrocodone Drug Has Successful Clinical Trial

Share on Facebook
Stamford, Conn.-based Purdue Pharma, the manufacturer of OxyContin, announced successful results from a stage three clinical trial on its hydrocodone drug designed to prevent misuse and abuse of the drug.

Read the full article on Becker's Hospital Review.

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

The road to ASC financial success: 10 supply chain cost-cutting strategies

Read Now


Becker's ASC Quality, Safety & Infection Control E-Weekly Sign Up

10 Most-Read Articles

Upcoming Events